Oncogenes and tumor suppressor genes in the carcinogenicity of fibers and particles

Inhalation Toxicology

Volumn 12, Issue SUPPL. 3, 2000, Pages 133-140

  Kane, A B ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CANCER SCREENING; CARCINOGENICITY; CHROMOSOMAL LOCALIZATION; CIGARETTE SMOKE; DISEASE DIAGNOSIS; GENE LOCUS; LUNG; MONOSOMY; ONCOGENE; POINT MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0033775924     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370050164978     Document Type: Conference Paper

References (41)

1. Malignant pleural mesothelioma
2. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
3. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas
4. p16 Alterations and deletion mapping of 9p21-p22 in malignant mesothelioma
5. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two-hit mechanism of NF2 inactivation
6. Tumors of the lower respiratory tract
7. Mutation of cell cycle regulators: Biological and clinical implications for human neoplasia
8. Human cancer syndromes: Clues to the origin and nature of cancer
9. Widely dispersed p53 mutation in respiratory epithelium: A novel mechanism for field carcinogenesis
10. Tobacco smoke carcinogens and lung cancer
11. Mesothelioma, asbestos, and reported history of cancer in first-degree relatives
12. Multiple primary cancers in families with Li-Fraumeni syndrome
13. K-ras mutations in human adenocarcinoma of the lung, association with smoking and occupational exposure to asbestos
14. Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure
15. Lung cancer and past occupational exposure to asbestos: Role of p53 and K-ras mutations
16. Overall evaluations of carcinogenicity: An updating of IARC monographs volumes 1 to 42
17. Silica, some silicates, coal dust and para-aramid fibrils
18. p53 Expression is common in malignant mesothelioma
19. Mechanisms of mineral fibre carcinogenesis
20. Animal models of malignant mesothelioma
21. p53 and bcl-2 expression in pneumoconiosis-related pre-cancerous lesions and lung cancers: Frequent and preferential p53 expression in pneumoconiotic bronchiolar dysplasias
22. Oncogenes and tumor-suppressor genes in mesothelioma-A synopsis
23. Genetic instabilities in human cancers
24. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens
25. The frequency of p53 immunostaining in asbestos-associated mesotheliomas and non-asbestos-associated mesotheliomas
26. p53 and Kirsten-ras mutations in human mesothelioma cell lines
27. Environmental factors as regulators and effectors of multipstep carcinogenesis
28. Cell signaling pathways elicited by asbestos
29. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma
30. Chromosome 3p14 alterations in lung cancer: Evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos
31. Cyclin D1 overexpression vs. retinoblastoma inactivation: Implications for growth control evasion in non-small cell and small cell lung cancer
32. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer
33. Multiple mechanisms of p16(INK4A) inactivation in non-small cell lung cancer cell lines
34. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black
35. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas
36. The role of oxygen free radicals in occupational and environmental lung disease
37. Li-Fraumeni syndrome - A molecular and clinical review
38. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure
39. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
40. A parallel in vitro sensitivity to benzo(a)pyrene diol expoxide and bleomycin in lung carcinoma cases and controls
41. Codeletion of p15 and p16 in primary malignant mesothelioma